Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Ovarian carcinoma

  • You have access
    Randomized Clinical Trials and Real World Prospective Observational Studies on Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Ovarian Carcinoma: A Critical Review
    ANGIOLO GADDUCCI and STEFANIA COSIO
    Anticancer Research October 2021, 41 (10) 4673-4685; DOI: https://doi.org/10.21873/anticanres.15281
  • You have access
    Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma
    OSAMU MAEDA, HIROAKI KAJIYAMA, KIYOSUMI SHIBATA, SHIGEO NAKAMURA and FUMITAKA KIKKAWA
    Anticancer Research May 2020, 40 (5) 2497-2507; DOI: https://doi.org/10.21873/anticanres.14220
  • You have access
    AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
    DESIRÈ M. ALAMPI, EMILIO CIUSANI, NIVES CARENINI, ELISABETTA CORNA, LAURA GATTI and CRISTINA CORNO
    Anticancer Research July 2019, 39 (7) 3803-3808; DOI: https://doi.org/10.21873/anticanres.13529
  • You have access
    Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma
    JI-YE KIM, SE HOON KIM and HYUN-SOO KIM
    Anticancer Research May 2019, 39 (5) 2361-2367; DOI: https://doi.org/10.21873/anticanres.13353
  • You have access
    Value of Diaphragmatic Surgery During Interval Debulking Surgery
    AURELIE PELISSIER, OONA FRANKE, EMILE DARAI, GILLES HOUVENAEGHEL, ELISABETH CHEREAU and ROMAN ROUZIER
    Anticancer Research January 2018, 38 (1) 411-416;
  • You have access
    Expression of Polypeptide N-Acetylgalactosaminyltransferase-6 in Epithelial Ovarian Carcinoma
    MIDORI MURAKAMI, SEIJI KAGAMI, THUY THI NGUYEN, CHIHO KOI, TOMOKO KURITA and TORU HACHISUGA
    Anticancer Research July 2017, 37 (7) 3911-3915;
  • You have access
    Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients
    LUDMILA LOZNEANU, PATRIZIA PINCIROLI, DELIA APOSTOL CIOBANU, MARIA LUISA CARCANGIU, SILVANA CANEVARI, ANTONELLA TOMASSETTI and IRINA-DRAGA CĂRUNTU
    Anticancer Research August 2016, 36 (8) 4155-4163;
  • You have access
    Correlation Between CA125 Levels After Sixth Cycle of Chemotherapy and Clinical Outcome in Advanced Ovarian Carcinoma
    ANGIOLO GADDUCCI, ALICE MENICHETTI, ILARIA GUIGGI, MARGHERITA NOTARNICOLA and STEFANIA COSIO
    Anticancer Research February 2015, 35 (2) 1099-1104;
  • You have access
    Distinct Expression and Localization of TNF System in Ovarian Carcinoma Tissues: Possible Involvement of TNF-α in Morphological Changes of Ovarian Cancerous Cells
    BENJAMIN PIURA, LIAT MEDINA, ALEX RABINOVICH, VICTOR DYOMIN, RUTHY SHACO LEVY and MAHMOUD HULEIHEL
    Anticancer Research February 2014, 34 (2) 745-752;
  • You have access
    How Liposomal Cisplatin Overcomes Chemoresistance in Ovarian Tumour Cells
    DANIEL PHILIPP STÖLTING, MICHAELA BORRMANN, MARTIN KOCH, MICHAEL WIESE, HANS-DIETER ROYER and GERD BENDAS
    Anticancer Research January 2014, 34 (1) 525-530;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire